KCI

KCI was a global medical technology company focused on advanced wound care and specialty surgical applications, best known for pioneering negative pressure wound therapy with its V.A.C. system. The company marketed KCI-branded products for wound healing, surgical incision management, advanced wound dressings, and tissue-based repair products through businesses including KCI, LifeCell, and Systagenix. Its offerings were used across hospital and surgical settings to improve healing outcomes and reduce total cost of care. KCI Holdings filed for an IPO but was acquired before listing, and the business became part of 3M's medical solutions operations. The company should be viewed primarily as a commercial-stage medtech and wound-care franchise rather than a therapeutic drug developer.